logo
Sign InSign Up

CENCORA INC (COR)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for COR, sign up here.

Income Statement

Revenue

$271.6bn

Gross Profit

$9.3bn

Earning before Tax

$2.4bn

Net Income

$1.9bn

Net Income Common Shareholders

$1.9bn

EPS

9.28

Balance Sheet

Cash

$2.9bn

Debt

$4.8bn

Assets

$64.7bn

Liabilities

$63.6bn

Equity

$911.7m

Enterprise Value

$43.4bn

Cash Flow Statement

Net Cash from Operations

$4.1bn

Net Cash from Investing

$-1.2bn

Net Cash from Financing

$-1.8bn

Net Cash Flow

$1.1bn

Free Cash Flow

$3.6bn

Free Cash Flow per Share

$18.14

Metrics

Price to Equity

22.08

Price to Equity (Damodaran)

22.13

Price to Book

45.22

Net Margin

0.01

Return on Equity

3.11

Return on Sales

0.01

Get immediate access to 5-years of reference grade data for COR for free.

Sign up

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products. The company''s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Company Info

Industry

Medical Distribution

Employees

42,000

Address

1 West First Avenue
Conshohocken, PA 19428-1800
United States

Phone

610 727 7000

Last Updated

2024-02-08

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy